cardiac arrest - Nursing Case Study

Pathophysiology

• Primary mechanism: Electrical malfunction – The heart's electrical system becomes erratic, leading to an abnormal heart rhythm known as ventricular fibrillation. This disrupts the coordinated contraction of the heart, preventing it from pumping blood effectively.

• Secondary mechanism: Ischemia – A lack of blood flow to the heart muscle, often due to a blockage in the coronary arteries, deprives the heart of oxygen and nutrients. This can damage the heart tissue and trigger electrical disturbances.

• Key complication: Circulatory collapse – The heart's inability to pump blood results in a sudden stop of circulation, depriving vital organs, including the brain, of oxygen. Immediate intervention, such as CPR and defibrillation, is crucial to restore normal rhythm and prevent organ damage.

Patient Profile

Demographics:

65-year-old male, retired school teacher

History:

• Key past medical history: Hypertension

• Current medications: Lisinopril 10 mg daily

• Allergies: None known

Current Presentation:

• Chief complaint: Sudden onset of chest discomfort

• Key symptoms: Mild chest pain, slight shortness of breath

• Vital signs: Blood pressure 130/85 mmHg, heart rate 78 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, oxygen saturation 97% on room air

Section 1

Initial Assessment Findings:

Upon arrival at the emergency department, the patient was immediately assessed by the nursing team. The patient appeared anxious but was alert and oriented to person, place, and time. His skin was pale and slightly clammy, indicating potential peripheral vasoconstriction. The chest discomfort was rated as a 6 out of 10 on the pain scale, localized to the central chest, with no radiation. The electrocardiogram (ECG) performed at the bedside revealed ventricular fibrillation, confirming the electrical malfunction and necessitating prompt intervention.

During the assessment, the patient’s vital signs were closely monitored. Blood pressure was stable at 130/85 mmHg, heart rate was elevated at 110 bpm, respiratory rate increased slightly to 22 breaths per minute, and oxygen saturation dropped to 94% on room air. The patient’s lungs were clear to auscultation bilaterally, and no jugular venous distention was noted. Peripheral pulses were present but weak, indicating compromised circulation. The immediate priority was to initiate advanced cardiac life support (ACLS) protocols, which included defibrillation to correct the arrhythmia and restore an effective cardiac rhythm.

These initial findings suggest the need for swift intervention to prevent further complications. The nursing team prepared to deliver a synchronized shock using the defibrillator and gathered necessary medications, such as amiodarone and epinephrine, to support cardiac function. This assessment phase set the stage for the critical interventions required to stabilize the patient and improve his prognosis.

Section 2

Response to Interventions:

Following the initial assessment, the nursing team proceeded with the ACLS protocol, delivering a synchronized shock to the patient using the defibrillator. The patient responded positively to the intervention, as evidenced by a return to sinus rhythm on the ECG monitor. The heart rate stabilized, decreasing to 85 bpm, and the patient reported a reduction in chest discomfort, now rating the pain as a 3 out of 10. Oxygen saturation improved to 97% with supplemental oxygen administered via nasal cannula at 2 liters per minute. These positive changes indicated an effective response to the initial defibrillation and supportive measures, providing a momentary relief to both the patient and healthcare team.

While continuing to monitor the patient closely, the nursing staff initiated an intravenous line to administer medications as part of the post-resuscitation care plan. Amiodarone was infused to prevent recurrence of ventricular fibrillation, and a low-dose epinephrine drip was prepared to maintain hemodynamic stability. Blood tests were conducted to assess cardiac enzymes, electrolyte levels, and complete blood count, aiming to identify any underlying conditions contributing to the cardiac event. The patient was kept under continuous observation with telemetry monitoring to detect any signs of arrhythmia recurrence.

Despite the initial improvement, the patient exhibited signs of fatigue and mild shortness of breath, prompting the team to maintain vigilance for potential complications such as heart failure or re-arrest. The nursing team communicated the updates to the attending physician and cardiology team, ensuring a collaborative approach to ongoing care. This careful monitoring and coordination laid the foundation for further diagnostic evaluation and adjustments to the treatment plan, optimizing the patient's recovery trajectory.

Section 3

As the nursing team continued their diligent monitoring of the patient, new diagnostic results began to arrive, providing further insight into the patient's condition. The blood tests revealed elevated cardiac enzyme levels, specifically troponin I at 0.5 ng/mL, suggesting myocardial injury. Electrolyte analysis showed a mild potassium imbalance, with a potassium level of 3.2 mEq/L, which could contribute to arrhythmias if not corrected. The complete blood count was within normal limits, ruling out any acute infections or hemoconcentration.

The ECG showed no new signs of ischemia, and the patient remained in sinus rhythm, which was reassuring. However, the echocardiogram performed at the bedside indicated a slight reduction in ejection fraction at 45%, suggesting early signs of left ventricular dysfunction. This finding necessitated careful management to prevent progression to heart failure. The cardiology team recommended initiating a low-dose beta-blocker to improve cardiac output and reduce myocardial oxygen demand.

In light of these findings, the nursing team adjusted the care plan to address the identified issues. Potassium supplementation was started to correct the imbalance, and dietary recommendations were made to further support electrolyte stability. The patient continued to receive supplemental oxygen and reported feeling more comfortable, though still experiencing some fatigue. The collaborative efforts of the healthcare team ensured that the patient was closely monitored, and plans were made for further evaluation and potential adjustment of the treatment strategy to optimize cardiac function and prevent complications as the patient's recovery journey progressed.

Section 4

As the nursing team continued to monitor the patient's progress, they were pleased to observe a positive response to the initial interventions. Within 24 hours of starting potassium supplementation, the patient's potassium levels improved to 3.8 mEq/L, moving closer to the normal range and reducing the risk of arrhythmias. The patient reported a slight decrease in fatigue and was able to engage in light activities with less discomfort. Vital signs remained stable, with a heart rate of 78 beats per minute, blood pressure at 118/76 mmHg, and oxygen saturation consistently above 96% on supplemental oxygen.

The introduction of a low-dose beta-blocker also appeared effective. The patient experienced fewer episodes of palpitations and showed no signs of adverse reactions such as bradycardia or hypotension. An additional ECG confirmed that the patient maintained sinus rhythm without new ischemic changes. This stability was reassuring and suggested that the medical regimen was well-tailored to the patient's condition.

Nevertheless, the nursing team remained vigilant for any new complications. They educated the patient about recognizing symptoms that could indicate worsening heart function, such as increased shortness of breath or swelling in the extremities. The collaboration between the nursing staff and the cardiology team continued to be crucial in ensuring the patient's safety and optimizing recovery. As the patient approached the next phase of care, plans were made for a gradual increase in activity level and a follow-up echocardiogram to reassess cardiac function, paving the way for potential discharge planning contingent upon continued improvement.

Section 5

As the patient continued to stabilize, the nursing team conducted a follow-up assessment to evaluate the effectiveness of the current treatment plan. During the physical examination, the patient appeared more alert and reported feeling less fatigued. The patient’s skin was warm and dry, and there was no evidence of edema in the extremities. Lung auscultation revealed clear breath sounds bilaterally, and the patient denied any increase in shortness of breath or chest discomfort. Vital signs remained within optimal ranges, with a heart rate of 76 beats per minute, blood pressure at 120/78 mmHg, and oxygen saturation at 97% on room air, indicating a successful weaning off supplemental oxygen.

To further assess cardiac function, the cardiology team ordered a follow-up echocardiogram. The results showed a slight improvement in left ventricular ejection fraction, now at 52%, which was a positive indicator of enhanced cardiac output. The echocardiogram also demonstrated no significant valvular abnormalities or pericardial effusion, reinforcing the effectiveness of the current medication regimen and ruling out immediate concerns for structural heart issues.

Despite these encouraging findings, the nursing team remained attentive to the potential for new complications. They advised the patient on the importance of adhering to the prescribed medications, dietary recommendations, and gradually increasing physical activity as tolerated. The team emphasized monitoring for signs of electrolyte imbalances or worsening heart function, such as unusual fatigue or changes in heart rhythm. Planning for the patient’s discharge began to take shape, with a focus on ensuring a safe transition home and scheduling regular follow-up appointments to monitor ongoing recovery and adjust the care plan as needed.